Sol-Gel Adds $9 Million
Sol-Gel Ltd., a Revohot, Israel-based developer of topical products for the dermatology market, has raised $9 million in new VC funding. Medica Venture Partners led the round, and was joined by return backers JVP and DSM Corporate Venturing. The company had previously raised around $16.5 million since 2003.
18 November 2008•2 mins read
